News
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...
In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban ...
21h
MarketBeat on MSNSarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesIn another tragic incident, Sarepta Therapeutics (NASDAQ: SRPT) saw a second death in connection with its Duchenne muscular ...
I am upgrading Dyne Therapeutics stock to a 'Buy' rating due to promising late-stage DM1 and DMD drug candidates and ...
46mon MSN
A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated ...
2h
Zacks Investment Research on MSNCan Casgevy Deliver a Turnaround for CRISPR Therapeutics?CRISPR Therapeutics’ CRSP first marketed product is the one-shot gene therapy Casgevy, approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications — ...
President Javier Milei's severe budget cuts to Argentina's public health system have led to a decline in care, particularly affecting cancer patients, according to experts, government workers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results